Wiggin and Dana Closes Transaction for CURE Innovation Commons

October 27, 2014

New Haven – Wiggin and Dana congratulates its client, Connecticut United for Research Excellence (CURE), on its newest project, CURE Innovation Commons. Wiggin and Dana has successfully brought to a close this highly visible Connecticut transaction. CURE collaborated with Pfizer and the State of Connecticut to create CURE Innovation Commons. Pfizer donated the building to CURE, and the State will provide over $4 million in funding to renovate and absorb early operating costs. CURE Innovation Commons will house premier lab space that, with various other design features, and great staffing, will become an accelerator/innovation center for the State, and primarily southeastern Connecticut.

Leading this transaction to completion was Elliot Kaiman, partner in Wiggin and Dana's Real Estate Department, along with Christine Morgan, counsel; Evan Kipperman, associate; Dimitrios Tournas, associate; and Beth Vitello, paralegal. The Wiggin and Dana team was instrumental in guiding the vision and persistence of CURE and its Board of Directors. The closing of this transaction is only the beginning of this project. Wiggin and Dana will be assisting CURE Innovation Commons with various execution phases of the venture, including commissioning, architectural, engineering, construction management, utilities, leasing, and other operational matters.

Wiggin and Dana has a long-standing relationship with CURE. The firm has served as outside counsel to CURE, and Wiggin and Dana partner Frank Marco is a member of CURE's executive committee and serves on the advisory committee for CURE Innovation Commons.

For more information about CURE Innovation Commons, please click here to view the press release issued by CURE.